Increased investment by manufacturers to introduce innovative products to the market is expected to drive growth, according to a new report released by Grand View Research.
The United States Varicose Veins Treatment Device Market the size should reach $ 706.3 million through 2026, by registering a 5.5% CAGR over the forecast period, according to a new report released by Grand View Research, Inc. The high prevalence of varicose veins due to risk factors such as obesity, pregnancy, sedentary lifestyle, and physical activities such as standing longer, is expected to drive the market growth.
The prevalence of venous disease is high in the population over 60 years of age at 26%, due to factors such as increasing age and the development of conditions such as hypertension and venous thrombosis. The incidence is lowest in the 0 to 17 age group at 17% and is mainly due to risk factors such as genetics, obesity and lifestyle disorders affecting the arteries and veins.
Growing technological advancements due to continuous R&D activities are expected to drive the varicose vein treatment devices market. Numerous ongoing clinical trials by major market players are investigating the use of new systems over traditional treatment methods to gain competitive advantage over existing devices. This increases competition in the market by improving the quality of the products introduced into the market. For example, in June 2019, the Lake Washington Vascular Center conducted a study based on patients with symptomatic varicose veins treated with venasic and endovenous thermal ablation.
Total spending by Americans on cosmetic surgical and non-surgical procedures combined was $ 13.5 billion in 2015. The percentage of non-surgical procedures increased 44% since 2011 and accounted for 42% of total spending on procedures. aesthetic. These statistics show that the market for varicose veins treatment devices is attractive for cosmetic purposes.
Browse the full report with the table of contents @ https://www.grandviewresearch.com/industry-analysis/us-varicose-vein-treatment-devices-market
Highlights of the United States Varicose Veins Treatment Devices Market Report
• By type, sclerotherapy accounted for the largest market share in 2018
• Medicare provides insurance for sclerotherapy procedures for varicose veins, resulting in its high uptake by healthcare providers and patients
• Some of the major players operating in the US varicose vein treatment device market are Medtronic plc; AngioDynamics, Inc .; Biolitec SA; Lumenis Ltd .; Syneron Medical Ltée; Energist Group; Eufoton srl; Quanta Systems SpA; and Teleflex, Inc.
• In February 2015, Medtronic (then Covidien) received pre-market approval from the United States Food and Drug Administration (FDA) for its new product, the VenaSeal Closure System, a minimally invasive system that uses a medical adhesive to close the damaged vein in patients with vein diseases
To request a copy of this report, please visit @ https://www.grandviewresearch.com/industry-analysis/us-varicose-vein-treatment-devices-market/request/rs1
Varicose Veins Treatment Device Market Segmentation In United States
Grand View Research has segmented the U.S. varicose vein treatment device market on the basis of type:
Varicose Veins Treatment Device Type Outlook (Revenue, USD Million, 2015 – 2026)
• Endovenous ablation
• Radiofrequency ablation
• Surgical ligation and stripping
Find out more or share your questions if any prior to purchase on this report @ https://www.grandviewresearch.com/inquiry/6844/ibb
Browse more related reports:
Canadian Varicose Veins Treatment Device Market Size, Share and Trend Analysis Report by Type (Endovenous Ablation, Sclerotherapy), By End Use (Ambulatory Care Unit, Hospitals, Venous Clinics), By Region and Segment Forecast, 2021-2028
About Grand View Research
Grand View Research is a California-based market research and consulting company headquartered in San Francisco. The company offers tailored advisory services to businesses to help them understand and explore their potential at scale. At the same time, Grand View Research responds to individual research needs to provide personalized research service.
Grand View Research is fully committed to providing the best research services in the industry. Our dedicated team of experienced analysts offer the full capacity and potential to precisely understand your research needs.
Company Name: Grand View Research, Inc.
Contact: Sherry James, Corporate Sales Specialist – United States
E-mail: Send an email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, USA
City: San Francisco
Country: United States